 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - GILLIS STEVEN
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-05-23 Purchase | 2016-05-25 5:44 pm | PHASERX Inc | PZRX | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC NELSEN ROBERT BYBEE CLINTON CRANDELL KEITH Director 10% Owner | 1,000,000 | $5 | $5,000,000 | 2,854,222 (Indirect Direct) | View |
| 2016-05-23 Sale | 2016-05-25 5:44 pm | PHASERX Inc | PZRX | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC NELSEN ROBERT BYBEE CLINTON CRANDELL KEITH Director 10% Owner | 680,059 | $0.01 | $6,801 | 2,854,222 (Indirect Direct) | View |
| 2017-10-30 Purchase | 2017-10-31 8:07 pm | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 300,000 | $3.05 | $915,000 | 3,026,057 (Indirect Direct) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0 | $0 | 3,436,456 (Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 9:08 pm | Sienna Biopharmaceuticals Inc. | SNNA | ARCH Venture Partners X LLC ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT GILLIS STEVEN 10% Owner | 2,165,800 | $2.5 | $5,414,500 | 1,865,800 (Indirect) | View |
| 2019-09-19 Purchase | 2019-09-23 8:48 pm | VBI VACCINES Inc | VBIV | GILLIS STEVEN Director | 10,000,000 | $0.5 | $5,000,000 | 13,026,057 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2015-08-13 Option Award | 2015-08-17 8:01 pm | N/A N/A | VBI VACCINES Inc | VBIV | GILLIS STEVEN Director 10% Owner | 650,000 | $2.1 | 4,047,830 (Indirect) | View |
| 2016-02-03 Option Award | 2016-02-25 5:57 pm | N/A 2026-02-03 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 8,800 | $2.8 | 8,800 (Direct) | View |
| 2016-05-23 Option Award | 2016-05-25 5:44 pm | N/A 2026-02-08 | PHASERX Inc | PZRX | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC NELSEN ROBERT BYBEE CLINTON CRANDELL KEITH Director 10% Owner | 9,385 | $1.81 | 2,854,222 (Direct) | View |
| 2016-06-01 Option Award | 2016-06-02 5:31 pm | N/A 2026-06-01 | PHASERX Inc | PZRX | GILLIS STEVEN Director 10% Owner | 31,023 | $5.08 | 31,023 (Direct) | View |
| 2017-03-20 Option Award | 2017-03-22 6:53 pm | N/A 2027-03-20 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 4,400 | $2.78 | 4,400 (Direct) | View |
| 2017-01-17 Exercise | 2017-03-31 8:20 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 6,377 | $2.5 | 15,000 (Direct) | View |
| 2017-01-17 Exercise | 2017-03-31 8:20 pm | N/A 2017-02-06 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 6,377 | $2.5 | 15,000 (Direct) | View |
| 2017-01-17 Option Award | 2017-03-31 8:20 pm | N/A 2027-01-26 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 15,000 | $3.79 | 15,000 (Direct) | View |
| 2017-05-25 Option Award | 2017-05-30 5:51 pm | N/A 2027-05-25 | PHASERX Inc | PZRX | GILLIS STEVEN Director 10% Owner | 14,000 | $1.0799 | 14,000 (Direct) | View |
| 2017-06-14 Exercise | 2017-06-16 6:05 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 37,500 (Direct) | View |
| 2017-06-14 Exercise | 2017-06-16 6:05 pm | N/A 2026-06-14 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 37,500 (Direct) | View |
| 2018-01-23 Option Award | 2018-01-25 3:42 pm | N/A 2028-01-23 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 100,000 | $4.19 | 100,000 (Direct) | View |
| 2018-03-27 Option Award | 2018-03-29 6:34 pm | N/A 2028-03-27 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 31,160 | $16 | 31,160 (Direct) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 6,068,695 | $0 | 0 (Indirect) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 4,683,238 | $0 | 0 (Indirect) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 1,385,457 | $0 | 0 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | 2018-04-03 2018-10-03 | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0.65 | 3,436,456 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | 2018-04-03 2023-04-03 | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0.75 | 3,436,456 (Indirect) | View |
| 2018-06-05 Option Award | 2018-06-06 6:00 pm | N/A 2028-06-05 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 124,000 | $0.468 | 124,000 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-25 9:23 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 18,750 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-25 9:23 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 18,750 (Direct) | View |
| 2019-01-31 Option Award | 2019-02-04 5:20 pm | N/A 2029-01-31 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 300,000 | $1.67 | 300,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 4:11 pm | N/A 2029-05-16 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 15,000 | $1.06 | 15,000 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:09 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-18 4:11 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 0 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-18 4:11 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 0 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 5:19 pm | N/A 2030-01-09 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 15,000 | $1.54 | 15,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 5:26 pm | N/A 2030-01-22 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 350,000 | $1.46 | 350,000 (Direct) | View |
| 2020-04-02 Option Award | 2020-04-06 12:00 pm | N/A 2030-04-02 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 10,000 | $1.28 | 10,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 5:25 pm | N/A 2030-06-10 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 18,000 | $16.32 | 18,000 (Direct) | View |